More Atopic Dermatitis Trials Using Standard Treatments as Active Comparators, Please
J Invest Dermatol
.
2017 Jun;137(6):1365-1366.
doi: 10.1016/j.jid.2017.02.963.
Epub 2017 Feb 27.
Authors
Sally R Wilkes
1
,
Helen Nankervis
1
,
Elsa Tavernier
2
,
Annabel Maruani
3
,
Hywel C Williams
4
Affiliations
1
Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK.
2
CHRU Tours, Clinical Investigation Center-INSERM 1415, France.
3
University Francois Rabelais Tours-EA 4275, Department of Dermatology, France.
4
Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK. Electronic address:
[email protected]
.
PMID:
28249793
DOI:
10.1016/j.jid.2017.02.963
No abstract available
Publication types
Letter
Comment
MeSH terms
Dermatitis, Atopic*
Eczema*
Humans
Tacrolimus
Substances
Tacrolimus